Molecular Profiling in Unknown Primary Cancer: Accuracy of Tissue of Origin Prediction

被引:86
作者
Greco, F. Anthony [1 ]
Spigel, David R. [1 ,2 ]
Yardley, Denise A. [1 ,2 ]
Erlander, Mark G. [3 ]
Ma, Xiao-Jun [3 ]
Hainsworth, John D. [1 ,2 ]
机构
[1] Tennessee Oncol PLLC, Nashville, TN USA
[2] Sarah Cannon Res Inst, Nashville, TN USA
[3] bioTheranostics Inc, San Diego, CA USA
关键词
Carcinoma of unknown primary site; Molecular profiling; Reverse transcriptase-polymerase chain reaction; Site-directed therapy; CHAIN-REACTION ASSAY; CARCINOMA; IDENTIFY; CLASSIFICATION;
D O I
10.1634/theoncologist.2009-0328
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction. This retrospective, multi-institutional study evaluated the accuracy of tissue-of-origin prediction by molecular profiling in patients with carcinoma of unknown primary site (CUP). Methods. Thirty-eight of 501 patients (7.6%) with CUP, seen in 2000-2008, had their latent primary site tumor subsequently identified during life. Twenty-eight of these patients (73.7%) had adequate initial tissue biopsies available for molecular profiling with a reverse transcriptase-polymerase chain reaction (RT-PCR) assay (Cancer Type ID; bioTheranostics, Inc., San Diego, CA). The assay was performed on formalin-fixed paraffin-embedded biopsy specimens in a blinded fashion, and the assay results were compared with clinicopathologic data and the actual latent primary sites. Results. Twenty of the 28 (71.4%) RT-PCR assays were successfully completed (eight biopsies had either insufficient tumor or poorly preserved RNA). Fifteen of the 20 assay predictions (75%) were correct (95% confidence interval, 60%-85%), corresponding to the actual latent primary sites identified after the initial diagnosis of CUP. Primary sites correctly identified included breast (four patients), ovary/primary peritoneal (four patients), non-small cell lung (three patients), colorectal (two patients), gastric (one patient), and melanoma (one patient). Three predictions were incorrect (intestinal, testicular, sarcoma) in patients with gastroesophageal, pancreatic, and non-small cell lung cancer, respectively, and two were unclassifiable in patients with non-small cell lung cancer. Clinicopathologic findings were helpful in suggesting the correct primary site in some patients and appear to complement the molecular assay findings. Conclusions. These data validate the reliability of this assay in predicting the primary site in CUP patients and may form the basis for more successful site-directed therapy, when used in concert with clinicopathologic data. The Oncologist 2010; 15: 500-506
引用
收藏
页码:500 / 506
页数:7
相关论文
共 13 条
[1]  
[Anonymous], 2008, Cancer: Principles and Practice of Oncology
[2]   Molecular Classification of Unknown Primary Cancer [J].
Bender, Richard A. ;
Erlander, Mark G. .
SEMINARS IN ONCOLOGY, 2009, 36 (01) :38-43
[3]   Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary [J].
Bridgewater, J. ;
van Laar, R. ;
Floore, A. ;
Van't Veer, L. .
BRITISH JOURNAL OF CANCER, 2008, 98 (08) :1425-1430
[4]  
Greco F Anthony, 2008, J Natl Compr Canc Netw, V6, P1061
[5]   Treatment for Patients With Unknown Primary Carcinoma and Unfavorable Prognostic Factors [J].
Greco, F. Anthony ;
Pavlidis, Nicholas .
SEMINARS IN ONCOLOGY, 2009, 36 (01) :65-74
[6]   Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary [J].
Horlings, Hugo M. ;
van Laar, Ryan K. ;
Kerst, Jan-Martijn ;
Helgason, Helgi H. ;
Wesseling, Jelle ;
van der Hoeven, Jacobus J. M. ;
Warmoes, Marc O. ;
Floore, Arno ;
Witteveen, Anke ;
Lahti-Domenici, Jaana ;
Glas, Annuska M. ;
Van't Veer, Laura J. ;
de Jong, Daphne .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (27) :4435-4441
[7]  
Ma XJ, 2006, ARCH PATHOL LAB MED, V130, P465
[8]   Multicenter Validation of a 1,550-Gene Expression Profile for Identification of Tumor Tissue of Origin [J].
Monzon, Federico A. ;
Lyons-Weiler, Maureen ;
Buturovic, Ljubomir J. ;
Rigl, C. Ted ;
Henner, W. David ;
Sciulli, Christin ;
Dumur, Catherine I. ;
Medeiros, Fabiola ;
Anderson, Glenda G. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15) :2503-2508
[9]   Pathologic Evaluation of Unknown Primary Cancer [J].
Oien, Karin A. .
SEMINARS IN ONCOLOGY, 2009, 36 (01) :8-37
[10]   Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: A systematic literature review [J].
Pentheroudakis, George ;
Greco, F. A. ;
Pavlidis, Nicholas .
CANCER TREATMENT REVIEWS, 2009, 35 (03) :221-227